Status:
COMPLETED
Tridimensional Geometric Modeling of the Breast
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Breast Cancer
Skin Elasticity
Eligibility:
FEMALE
18-90 years
Phase:
NA
Brief Summary
The use of a personalized 3D model of the breast in the management of breast cancer would be very useful to help the surgeon better understand the three-dimensional location of tumors in the operative...
Detailed Description
Breast cancer is the most common cancer in France. Its screening and diagnosis use mammography, ultrasound and MRI. These imaging only show the topography of the tumors in the breast volume in two dim...
Eligibility Criteria
Inclusion
- Female
- Up to 18 years old
- Understanding and acceptance of the protocol
Exclusion
- Person protected by law under guardianship or curatorship
- Failure to obtain free, informed and written consent after a reflection period
- A patient who is not a member or beneficiary of a national health insurance system
- Patient with a skin disease or a skin lesion
- Person deprived of liberty by judicial or administrative decision
- Application of a cream on the skin within 12 hours before the measurements
Key Trial Info
Start Date :
March 31 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 22 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05301998
Start Date
March 31 2022
End Date
August 22 2022
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Montpellier
Montpellier, Outside of the US, France, 34090